Biotech Altimmune raises $75M for Phase 3 MASH liver drug trial
17M new shares and pre-funded warrants bring Altimmune about $75M in gross proceeds to back its planned Phase 3 MASH trial and other needs.
www.stocktitan.netI don’t have live access to up-to-the-minute news right now. Based on recent public signals, here’s what’s circulating about LOOKSMAXXER - ALT and related topics:
- It appears LOOKSMAXXER is sometimes discussed alongside AltLayer (ALT) in crypto/video content, with several videos claiming updates on ALT staking phases, security audits, and price targets in 2026. If you’re tracking LOOKSMAXXER specifically as a channel or persona, the strongest signals are coming from crypto YouTube channels that cover ALT-related news and potential price catalysts.[1][3][7]
- ALT-related coverage in early 2026 has highlighted staking phase updates, EigenLayer integrations, and security audits as notable events that could influence sentiment among ALT holders and restakers.[3][7][1]
- Market chatter and price tracking sources for ALT show periodic volatility around key unlocks and audit milestones, though exact price targets and timing vary across analyses.[5][7]
- There are unrelated looksmaxxer/looksmaxxing content online that occasionally appear in trending videos, but these are not authoritative crypto signals and should be treated separately from ALT ecosystem updates.[9]
If you want, I can:
- Narrow to LOOKSMAXXER-specific content (e.g., searches, social posts, or YouTube videos mentioning LOOKSMAXXER in relation to ALT).
- Gather a focused set of verified ALT ecosystem updates (Phase 3 staking, EigenLayer integrations, SOC 2/ISO audits) with citations.
- Provide a quick summary of ALT’s recent milestones and any notable news anchors that could affect its price or adoption.
Would you like me to tighten the search to LOOKSMAXXER mentions or focus on confirmed ALT developments with reliable sources? I can also prepare a concise timeline of ALT-related milestones from 2026 sources with citations.